Company Syngene International Limited Bombay S.E.
Equities
SYNGENE
INE398R01022
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
715.5 INR | -0.08% |
|
+1.40% | +2.05% |
Business Summary
Number of employees: 6,847
Sales per Business
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Contract Research and Manufacturing Services
96.5
%
| 25,067 | 96.3 % | 30,802 | 96.5 % | +22.88% |
Others
3.4
%
| 953 | 3.7 % | 1,077 | 3.4 % | +13.01% |
Scrap
0.2
%
| 22 | 0.1 % | 50 | 0.2 % | +127.27% |
Sales per region
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
71.8
%
| 18,782 | 72.1 % | 22,918 | 71.8 % | +22.02% |
Europe
17.9
%
| - | - | 5,711 | 17.9 % | - |
Rest of the World
6.5
%
| 4,471 | 17.2 % | 2,083 | 6.5 % | -53.41% |
India
3.8
%
| 2,789 | 10.7 % | 1,217 | 3.8 % | -56.36% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jonathan Hunt
CEO | Chief Executive Officer | 55 | 01/15/01 |
Sibaji Biswas
DFI | Director of Finance/CFO | - | 18/19/18 |
Chairman | 71 | 18/94/18 | |
Compliance Officer | - | 24/19/24 | |
Krishnan G.
IRC | Investor Relations Contact | - | 01/20/01 |
Andrew Webster
HRO | Human Resources Officer | - | 01/22/01 |
Alok Mehrotra
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | 01/19/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 71 | 18/94/18 | |
Director/Board Member | 67 | 31/17/31 | |
Jonathan Hunt
CEO | Chief Executive Officer | 55 | 01/15/01 |
Kush Parmar
BRD | Director/Board Member | 42 | 22/21/22 |
Paul Blackburn
BRD | Director/Board Member | 70 | 26/14/26 |
Director/Board Member | 63 | 08/00/08 | |
Director/Board Member | 69 | 01/17/01 | |
Director/Board Member | 59 | 01/19/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 402,536,981 | 179,829,914 ( 44.67 %) | 1,243,697 ( 0.3090 %) | 44.67 % |
Company contact information
Syngene International Ltd.
Biocon Park, Biocon SEZ Bommasandra Indl Area, IV Phase
560099, Bangalore
+91 80 6891 9191
http://www.syngeneintl.com![address Syngene International Limited(SYNGENE)](https://cdn.zonebourse.com/static/address/46731329.png)
Group companies
Name | Category and Sector |
---|---|
Syngene Scientific Solutions Ltd.
|
Sector
Sales per Business
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.72% | 44.44B | |
-10.33% | 37.99B | |
+37.55% | 37.75B | |
+29.36% | 30.78B | |
-8.44% | 27.38B | |
+12.45% | 26.17B | |
+44.19% | 14.15B | |
+31.93% | 12.59B | |
-7.67% | 11.28B |
- Stock Market
- Equities
- SYNGENE Stock
- SYNGENE Stock
- Company Syngene International Limited